UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003543
Receipt number R000004225
Scientific Title A Prospective Controlled Multi-Center Study on METAL-ON-METAL Total Hip Arthroplasty
Date of disclosure of the study information 2010/05/20
Last modified on 2010/04/26 19:01:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Prospective Controlled Multi-Center Study on METAL-ON-METAL Total Hip Arthroplasty

Acronym

Metal-on-Metal Study

Scientific Title

A Prospective Controlled Multi-Center Study on METAL-ON-METAL Total Hip Arthroplasty

Scientific Title:Acronym

Metal-on-Metal Study

Region

Japan Asia(except Japan)


Condition

Condition

Patients suitable for primary Total Hip Replacement

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate clinicl efficacy and performance of Metal-on-Metal Total Hip Arthroplasty

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Range of Motion, Dislocation Rate, Adverse Events

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Device: M2a Magnum
Observation period: Post-Op 2 year (Maximal length 10 year)

Interventions/Control_2

Device: M2a Taper
Observation period: Post-Op 2 year (Maximal length 10 year)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients suitable for primary Total Hip Replacement.
Patients with limited co-morbidity - ASA I - III.
Patients must be able to understand instructions and be willing to return for follow-up.

Key exclusion criteria

Pre-existing metal implants.
Absolute contraindications include: infection, sepsis, and osteomyelitis.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kenji Ohzono

Organization

Kansai Rosai Hospital

Division name

Orthopaedic Surgery

Zip code


Address

3-1-69 inobaso, Amagasaki City, Hyogo Pref.

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kansai Medical University Takii Hospital

Division name

Orthpaedic Surgery

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

Biomet Japan, Inc.

Institute

Department

Personal name



Funding Source

Organization

Biomet Japan, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

NCT01010763

Org. issuing International ID_1

ClinicalTraials.gov

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 05 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2009 Year 07 Month 29 Day

Date of IRB


Anticipated trial start date

2009 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 04 Month 26 Day

Last modified on

2010 Year 04 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004225


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name